Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

    Timing of Hepatitis C Virus Treatment Initiation
    • Multiple international guidelines agree that HCV treatment should be considered in the HCV/HIV-coinfected person
      • Immediate treatment should be prioritized in HCV/HIV-coinfected patients due to increased risk of hepatic complications (Management Guidelines)[AASLD-IDSA HCV]
      • In patients with CD4+ cell count < 200 cells/mm3, it may be preferable to improve the CD4+ cell count by initiating ART before HCV treatment
    Treatment Options
      Genotype 1 HCV/HIV Coinfection
        Non–Genotype 1 HCV

      Action required

      Keywords: Hepatic Complications, Special Populations, Treatment Complications, Viral Hepatitis Coinfection

      ©2018 Clinical Care Options, LLC. All Rights Reserved.

      The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.